NCT03227835View on ClinicalTrials.gov

Contrast-Induced Nephropathy After Revision of the Prophylaxis Threshold

CompletedOBSERVATIONAL
Enrollment

1,372

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

July 1, 2018

Study Completion Date

August 1, 2018

Conditions
Contrast-induced Nephropathy
Interventions
OTHER

intravascular iodinated contrast material administration

Evaluation of the consequences of the protocol change to not giving prophylaxis to patients with an eGFR \>29mL/min/1.73m2

Trial Locations (1)

6202AZ

Maastricht University Medical Center, Maastricht

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER

NCT03227835 - Contrast-Induced Nephropathy After Revision of the Prophylaxis Threshold | Biotech Hunter | Biotech Hunter